Skip to main content
Join The Community

Investing, Stocks, Stocks to Buy

Tempus AI Stock Looks Risky, But Its Data Flywheel Could Be Powerful

By Rick Orford · June 8, 2026

Tempus AI (NASDAQ:TEM) sits at the intersection of artificial intelligence, genomics, oncology, and drug development. That combination has created a compelling growth story, especially as the company expands artificial intelligence tools and biopharma partnerships. The stock’s challenge is simple: growth is impressive, but Wall Street still needs proof that the model can scale profitably.

Stock prices used were the market prices of June 1, 2026. The video was published on June 7, 2026. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video.

Watch the latest stock breakdowns on YouTube

New videos on stocks, options income and dividends from Rick Orford. Subscribe so you never miss one.